These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Down-regulation of PKHD1 induces cell apoptosis through PI3K and NF-κB pathways. Sun L; Wang S; Hu C; Zhang X Exp Cell Res; 2011 Apr; 317(7):932-40. PubMed ID: 21300060 [TBL] [Abstract][Full Text] [Related]
8. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas. Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006 [TBL] [Abstract][Full Text] [Related]
9. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas. Lin F; Zhang PL; Yang XJ; Prichard JW; Lun M; Brown RE Ann Clin Lab Sci; 2006; 36(3):283-93. PubMed ID: 16951269 [TBL] [Abstract][Full Text] [Related]
10. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750 [TBL] [Abstract][Full Text] [Related]
11. Cilia and polycystic kidney disease. Ma M Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708 [TBL] [Abstract][Full Text] [Related]
13. The cytoplasmic tail of FPC antagonizes the full-length protein in the regulation of mTOR pathway. Wang S; Wu M; Yao G; Zhang J; Zhou J PLoS One; 2014; 9(5):e95630. PubMed ID: 24851866 [TBL] [Abstract][Full Text] [Related]
14. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Ward CJ; Yuan D; Masyuk TV; Wang X; Punyashthiti R; Whelan S; Bacallao R; Torra R; LaRusso NF; Torres VE; Harris PC Hum Mol Genet; 2003 Oct; 12(20):2703-10. PubMed ID: 12925574 [TBL] [Abstract][Full Text] [Related]
15. Successful transplantation in a child with rapid progression of autosomal recessive polycystic kidney disease associated with a novel mutation. Prelog M; Bergmann C; Ausserlechner MJ; Fischer H; Margreiter R; Gassner I; Brunner A; Jungraithmayr TC; Zerres K; Sergi C; Zimmerhackl LB Pediatr Transplant; 2006 May; 10(3):362-6. PubMed ID: 16677362 [TBL] [Abstract][Full Text] [Related]
16. Altered Hippo signalling in polycystic kidney disease. Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034 [TBL] [Abstract][Full Text] [Related]
17. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2. Chen SJ; Nakahara T; Takahara M; Kido M; Dugu L; Uchi H; Takeuchi S; Tu YT; Moroi Y; Furue M Br J Dermatol; 2009 Feb; 160(2):442-5. PubMed ID: 19016696 [TBL] [Abstract][Full Text] [Related]
18. [From gene to disease; PKHD1 and recessive polycystic kidney disease]. Peters DJ; Losekoot M; de Die-Smulders CE; Stevens-Baldewijns M; Breuning MH Ned Tijdschr Geneeskd; 2005 Feb; 149(9):463-6. PubMed ID: 15771341 [TBL] [Abstract][Full Text] [Related]
19. Multi-exon deletions of the PKHD1 gene cause autosomal recessive polycystic kidney disease (ARPKD). Bergmann C; Küpper F; Schmitt CP; Vester U; Neuhaus TJ; Senderek J; Zerres K J Med Genet; 2005 Oct; 42(10):e63. PubMed ID: 16199545 [TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease. Obeidova L; Seeman T; Elisakova V; Reiterova J; Puchmajerova A; Stekrova J BMC Med Genet; 2015 Dec; 16():116. PubMed ID: 26695994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]